Cargando…
Notch inhibitors induce diarrhea, hypercrinia and secretory cell metaplasia in the human colon
In humans, inhibition of Notch oncogenic signaling leads to tumor regression. Preclinical studies indicate that Notch signaling contributes to the maintenance of intestinal homeostasis. Here, we sought to describe the intestinal effects of a first-in-human Notch inhibitor in an indication of refract...
Autores principales: | Collins, Michael, Michot, Jean-Marie, Bellanger, Christophe, Mussini, Charlotte, Benhadji, Karim, Massard, Christophe, Carbonnel, Franck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192874/ https://www.ncbi.nlm.nih.gov/pubmed/34121974 http://dx.doi.org/10.17179/excli2021-3572 |
Ejemplares similares
-
Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma
por: Even, C., et al.
Publicado: (2019) -
Downregulation of Notch Signaling in Kras-Induced Gastric Metaplasia
por: Chung, Wen-Cheng, et al.
Publicado: (2019) -
Refractory Hypokalemia in Secretory Diarrhea Phenotype of Colonic Pseudo-Obstruction (Ogilvie's Syndrome)
por: Hazzazi, Ahmad A, et al.
Publicado: (2022) -
A phase 1 study of crenigacestat (LY3039478), the Notch inhibitor, in Japanese patients with advanced solid tumors
por: Doi, Toshihiko, et al.
Publicado: (2020) -
ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer
por: Fizazi, Karim, et al.
Publicado: (2015)